![Anthony Ting](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Ting is currently the Chief Commercialization Officer at the International Society for Cell & Gene Therapy.
Previously, he worked as the Chief Scientific Officer at Bone Therapeutics SA. He received his undergraduate degree from Amherst College and his doctorate from The Johns Hopkins University.
| Companies | Position | Start |
|---|---|---|
International Society For Cell & Gene Therapy | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| BIOSENIC SA | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bone Therapeutics SA
 Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops regenerative therapy products for addressing unmet medical needs in the field of bone diseases and orthopedics | Health Technology |
International Society For Cell & Gene Therapy |
Select your edition
All financial news and data tailored to specific country editions
